American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

BCCCP/BCEMP Clinical Session — To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

Monday, October 14, 2024 from 12:30 PM to 2:00 PM MST at Convention Center North Building / Meeting Room 122

Available for 1.50 hours of CPE credit
Activity Number: 0204-9999-24-327-L01
Activity Type: An Application-Based Activity

Given the urgency and gravity of the decision to reverse anticoagulation, it is important for pharmacists to be aware of the key patient-specific factors that will influence patient safety. While some clinical scenarios necessitate anticoagulation reversal, these are accompanied by the potential for further complications. Using patient cases, this interactive session will provide a comprehensive overview of the various strategies for individual anticoagulant reversal, including agent selection, laboratory monitoring, and pharmacokinetic data while initially weighing the risk versus benefit of anticoagulation reversal and the approach to agent selection. New and emerging data that may influence clinical and operational pharmacy decisions (e.g., agents, formulary management) will also be presented.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) and Board Certified Emergency Medicine Pharmacist (BCEMP) recertification credit.

The BCCCP/BCEMP Clinical Sessions are part of the professional development program for the recertification of board-certified Critical Care and Emergency Medicine pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCCCP/BCEMP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest. Access to the BCCCP/BCEMP Clinical Sessions posttests will be available on December 18, 2024, at www.accp.com/myaccount to anyone who has purchased access to the BCCCP or BCEMP posttests. For participants who have not purchased access to the posttest, access can be purchased until 5:30 p.m. on Tuesday, October 15, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 16, 2025. 

Learning Objectives

1. Summarize available anticoagulant reversal agents and literature surrounding their use.

2. Evaluate the main pillars of anticoagulation reversal to assess when reversal is clinically appropriate.

3. Develop a comprehensive anticoagulation reversal plan with consideration of patient-specific factors.

Dareen M. Kanaan, Pharm.D.,  MPH, BCCP
Speaker:Dareen M. Kanaan, Pharm.D., MPH, BCCP

Clinical Pharmacy Specialist III

Brigham and Women’s Hospital

Boston, MA

  View Biography
Lena Tran, Pharm.D., BCCCP
Speaker:Lena Tran, Pharm.D., BCCCP

Clinical Pharmacist Specialist

AdventHealth Central Florida

Kissimmee, FL

  View Biography

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.